Home › Malattie polmonari › Tennessee › Nashville
Studi clinici su Malattie polmonari a Nashville, TN
10 studi su Malattie polmonari cercano partecipanti presso sedi a Nashville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
In reclutamentoFase 3
- SCRI Oncology Partners, Nashville
American Lung Association (ALA) Lung Health Cohort
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Vanderbilt University Medical Center, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- Sarah Cannon Research Institue, Nashville
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
In reclutamentoFase 2
- Premier Research Center, LLC, Hendersonville · a 13 mi di distanza
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
In reclutamentoFase 2
- Vanderbilt University Medical Center, Nashville
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
In reclutamentoFase 3
- Clinical Trials Center of Middle Tennesee LLC, Franklin · a 17 mi di distanza
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
In reclutamentoFase 2
- SCRI Oncology Partners, Nashville
Cooperative Assessment of Late Effects for SCD Curative Therapies
In reclutamentoStudio osservazionale
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
In reclutamentoFase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Studi su Malattie polmonari in altre città
- Houston, TX15 studi
- Boston, MA14 studi
- Durham, NC13 studi
- New York City, NY12 studi
- Pittsburgh, PA11 studi
- Los Angeles, CA10 studi
- Columbus, OH10 studi
- Dallas, TX10 studi
- Washington, DC10 studi
- Miami, FL10 studi
- Ann Arbor, MI10 studi
- Chicago, IL9 studi
Altri studi a Nashville
- Cancro del polmone non a piccole cellule97 studi
- Cancro al seno80 studi
- Cancro metastatico70 studi
- Cancro colorettale69 studi
- Cancro (tutti i tipi)65 studi
- Cancro ovarico49 studi
- Cancro alla prostata42 studi
- Cancro ai polmoni40 studi
- Carcinoma a cellule squamose della testa e del collo39 studi
- Cancro pancreatico39 studi
- Cancro dell'endometrio38 studi
- Melanoma33 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.